BIOA as of Nov 3 · 05:26 ET
BIOANasdaqPharmaceutical Preparations
BioAge Labs, Inc. · Brief
Next report
2 days
Nov 5 · after closeest.Q3 FY26
Expected move
Inputs0 of 7≥ implied
- avg implied
- ±26.2%
- avg realized
- ±3.6%
Nov 7 '24—▲+7.61%—
Mar 20 '25±8.3%▲+2.51%×0.30
May 6 '25±14.5%▲+2.78%×0.19
Aug 6 '25±58.8%▼−0.23%×0.00
Q3 FY25±15.6%▼−2.81%×0.18
Q1 FY26±16.5%▼−13.53%×0.82
May 8 '26±10.8%▲+0.95%×0.09
Q2 FY26±59.0%▲+2.64%×0.04
quarterimplied−60%0+60%realized×
Q2 FY26±59.0%▲+2.64%×0.04
May '26±10.8%▲+0.95%×0.09
Q1 FY26±16.5%▼−13.53%×0.82
Q3 FY25±15.6%▼−2.81%×0.18
Aug '25±58.8%▼−0.23%×0.00
May '25±14.5%▲+2.78%×0.19
2 older reports
Mar '25±8.3%▲+2.51%×0.30
Nov '24—▲+7.61%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 5 report · est.Bull2
+1.26%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
Bear2 of 3
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
BIOA report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.